Startup India Government of India
Urihk Pharmaceutical Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.62 Cr
▼ 19% YoY
Net loss · FY 2025
₹8.49 Cr
Net margin -98.5%
EBITDA · FY 2025
-₹7.8 Cr
EBITDA margin -90.5%
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹19.82 Cr
Issued & subscribed
Company age
9 yrs
Est. 2017
Employees · EPFO
79
Provident fund records
Directors on board
4
As per MCA filings
About Urihk Pharmaceutical Private Limited
Data last updated:
Urihk Pharmaceutical Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ureka Hong Kong Limited and recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017FTC302652. Its GSTIN is 27AACCU1777F1Z8 (Maharashtra). The company holds 8 GST registrations, of which 7 are active.
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹19.82 Cr. It is led by directors including Rajesh Madanlal Gupta (Whole-Time Director) and Tarun Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 603 Sai Samarth Business Park, Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.62 Cr, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹8.49 Cr (net margin -98.5%) and EBITDA of -₹7.8 Cr (EBITDA margin -90.5%). Revenue has declined at a compounded annual rate (CAGR) of 36% over three years and 3% over five years.
The company has about 79 employees on its provident fund (EPFO) records.
Urihk Pharmaceutical Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0005507). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website urihkpharma.com.
Company Details of Urihk Pharmaceutical Private Limited
CIN U51909MH2017FTC302652
Registration Number 302652
Incorporation Date 08 December 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Ureka Hong Kong Limited
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-MH-18-0005507
Recognitions & Rankings of Urihk Pharmaceutical
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0005507
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressOffice No. 602 – 603 Sai Samarth Business Park Near Wasan Motors Deonar Govandi (East, ), Mumbai, Maharashtra, India – 400088
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Urihk Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Urihk Pharmaceutical Private Limited
The main business activity of Urihk Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Urihk Pharmaceutical Private Limited FY 2025 filings available
Urihk Pharmaceutical Private Limited reported revenue of ₹8.62 Cr (down 19% YoY) for FY 2025.
Revenue · FY 2025
₹8.62 Cr ▼ 19%
Net loss · FY 2025
₹8.49 Cr margin -98.5%
EBITDA · FY 2025
-₹7.8 Cr margin -90.5%
Compounded Annual Growth Rate (CAGR) of Urihk Pharmaceutical Private Limited
Revenue CAGR growth
1 year
▼ 19%
3 years · compounded
▼ 36%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 7%
5 years · compounded
▲ 10%
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 19% fall in the latest year. EBITDA rose 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Urihk Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹7.8 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹8.49 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Urihk Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -90.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -98.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Urihk Pharmaceutical are in the company report.
Premium access
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Urihk Pharmaceutical Private Limited
Urihk Pharmaceutical has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Madanlal Gupta Also directs: Joint Force Pharmachem Private Limited, STG Pharmagenerics Private Limited, Serendipity Speciality Foods Private Limited and 1 more | Whole-Time Director | 08 Dec 2017 | 8 Years 10 Months | Current |
| Tarun Gupta | Director | 08 Dec 2017 | 8 Years 10 Months | Current |
| Rajesh Sharma Also directs: Factum Associates LLP, Avance Medical Systems LLP | Director | 01 Jan 2020 | 6 Years 9 Months | Current |
| Xuekui Chen | Director | 13 Apr 2018 | 8 Years 6 Months | Current |
Peer Comparison of Urihk Pharmaceutical Private Limited
Urihk Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shukan Colotex Chemestry Private Limited | ₹8.64 Cr (FY 2017) | •••• | •••• | 21.0% | •••• | Ahmedabad, Gujarat, India |
| Prajna Generics Private Limited | ₹8.64 Cr (FY 2022) | •••• | •••• | 3.0% | •••• | Telangana, India |
| MSK Pharmaceuticals Private Limited | ₹8.64 Cr (FY 2025) | •••• | •••• | 55.0% | •••• | Saraipali, Chhattisgarh, India |
| Nansika Enterprises Private Limited | ₹8.63 Cr (FY 2025) | •••• | •••• | 2148.0% | •••• | New Delhi, Delhi, India |
| Kanad Labs Private Limited | ₹8.63 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Nagpur, Maharashtra, India |
| Urihk Pharmaceutical Private Limited this company | ₹8.62 Cr (FY 2025) | •••• | •••• | -19.0% | •••• | Mumbai, Maharashtra, India |
| Orgyn Laboratories Private Limited | ₹8.59 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | New Delhi, Delhi, India |
| CPH Center Point Hospital & Medical Research Institute Private Limited | ₹8.59 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Nagpur, Maharashtra, India |
| Biomed (I) Healthcare Private Limited | ₹8.58 Cr (FY 2019) | •••• | •••• | -4.0% | •••• | Hyderabad, Telangana, India |
| Modasa Pharmaceuticals Private Limited | ₹8.58 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Modasa, Gujarat, India |
| S.S. Lifecare Private Limited | ₹8.56 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Faridabad, Haryana, India |
Peers are the five companies nearest above and the five nearest below Urihk Pharmaceutical by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Urihk Pharmaceutical Private Limited
Urihk Pharmaceutical Private Limited is audited by A M JAIN & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A M JAIN & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Urihk Pharmaceutical Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Urihk Pharmaceutical Private Limited
Urihk Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
MSME Payment Delays by Urihk Pharmaceutical Private Limited
Urihk Pharmaceutical Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2022, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pharmasofttech Awacs Private Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Urihk Pharmaceutical Private Limited
Urihk Pharmaceutical Private Limited has a workforce of 79 employees as of Mar 28, 2024.
Employee count
79
Active EPFO establishments
1
Employee growth
-15.05%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Urihk Pharmaceutical Private Limited
Urihk Pharmaceutical Private Limited has 8 board changes on record since 2017: 4 appointments and 4 cessations. The latest: Rajesh Sharma ceased to be Additional Director on 09 Nov 2020.
AGM
Urihk Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Urihk Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Rajesh Sharma ceased to be Additional Director.
Appointed
Rajesh Sharma was appointed as Director.
Ceased
Jaspinder Singh ceased to be Company Secretary.
Ceased
Xinpei Yu ceased to be Additional Director.
Ceased
Xuekui Chen ceased to be Additional Director.
Appointed
Xuekui Chen was appointed as Director.
Appointed
Rajesh Madanlal Gupta was appointed as Whole-Time Director.
Appointed
Tarun Gupta was appointed as Director.
Incorporation
08 Dec 2017
Urihk Pharmaceutical Private Limited was registered on 08 Dec 2017 with Roc Mumbai & aged 8 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Urihk Pharmaceutical Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Urihk Pharmaceutical Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Urihk Pharmaceutical Private Limited
Urihk Pharmaceutical has 8 GST registrations: 7 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
8
Active
7
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCU1777F1Z8 | Maharashtra | Active | 30 Jan 2018 |
| 09AACCU1777F1Z6 | Uttar Pradesh | Active | 15 Sep 2021 |
| 06AACCU1777F1ZC | Haryana | Active | 22 Sep 2021 |
| 29AACCU1777F1Z4 | Karnataka | Active | 04 Nov 2021 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Urihk Pharmaceutical Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Urihk Pharmaceutical Private Limited
Urihk Pharmaceutical is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 December 2017 (9+ years old) and is registered under CIN U51909MH2017FTC302652.
Urihk Pharmaceutical reported revenue of ₹8.62 Cr for FY 2025 (down 19% YoY).
Urihk Pharmaceutical has 4 current directors:
- Rajesh Madanlal Gupta - Whole-Time Director
- Tarun Gupta - Director
- Rajesh Sharma - Director
- Xuekui Chen - Director
Urihk Pharmaceutical reported a net loss of ₹8.49 Cr (net margin -98.5%) and EBITDA of -₹7.8 Cr (EBITDA margin -90.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Urihk Pharmaceutical is -36% over three years and -3% over five years. In the latest year (FY 2025) revenue fell 19%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Urihk Pharmaceutical is 27AACCU1777F1Z8, registered in Maharashtra. The company has 8 GST registrations in all, of which 7 are active and 1 is cancelled or inactive. Other active GSTINs include 09AACCU1777F1Z6 (Uttar Pradesh), 06AACCU1777F1ZC (Haryana), 29AACCU1777F1Z4 (Karnataka).
The CIN (Corporate Identification Number) of Urihk Pharmaceutical is U51909MH2017FTC302652. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Urihk Pharmaceutical was incorporated on 08 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Urihk Pharmaceutical by revenue are Shukan Colotex Chemestry Private Limited, Prajna Generics Private Limited, MSK Pharmaceuticals Private Limited, Nansika Enterprises Private Limited, Kanad Labs Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Rajesh Sharma ceased to be Additional Director on 09 Nov 2020. Rajesh Sharma was appointed as Director on 01 Jan 2020. Jaspinder Singh ceased to be Company Secretary on 05 Sep 2019. Urihk Pharmaceutical has 8 board changes on record in total.
Yes, Urihk Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Urihk Pharmaceutical is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0005507).